Quest Diagnostics (DGX) Deferred Taxes (2009 - 2026)

Quest Diagnostics has disclosed Deferred Taxes across 18 years of filings, most recently posting $48.0 million for Q1 2026.

• Deferred Taxes for Q1 2026 came in at $48.0 million, up 585.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $146.0 million (up 284.21% YoY), and the FY2025 annual result was $105.0 million, up 707.69% from the prior year.
• Deferred Taxes came in at $48.0 million for Q1 2026 at Quest Diagnostics, up from -$13.0 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $110.0 million in Q3 2025 to a low of -$44.0 million in Q4 2022.
• The 5-year median for Deferred Taxes is -$4.0 million (2023), against an average of $6.9 million.
• Across the five-year window, Deferred Taxes surged 3150.0% in 2022 and slumped 350.0% in 2024, its largest moves.
• Quest Diagnostics' Deferred Taxes stood at -$44.0 million in 2022, then jumped by 77.27% to -$10.0 million in 2023, then surged by 440.0% to $34.0 million in 2024, then tumbled by 138.24% to -$13.0 million in 2025, then surged by 469.23% to $48.0 million in 2026.
• The last three Deferred Taxes figures came in at $48.0 million (Q1 2026), -$13.0 million (Q4 2025), and $110.0 million (Q3 2025), per Business Quant data.